C. Ottiger
Pharmacokinetic properties and interactions with blood components of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine (NHAC) incorporated into liposomes
Horber D, Ottiger C, Schott H, Schwendener R. Pharmacokinetic properties and interactions with blood components of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine (NHAC) incorporated into liposomes. J Pharm Pharmacol 1995; 47:282-288.
12.04.1995Pharmacokinetic properties and interactions with blood components of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine (NHAC) incorporated into liposomes
12.04.1995J Pharm Pharmacol 1995; 47:282-288
Horber Daniel, Ottiger C., Schott H., Schwendener R.
Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC
Schwendener R, Horber D, Ottiger C, Rentsch K, Fiebig H, Schott H. Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC. Drugs of the Future 1995; 20:11-15.
01.01.1995Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC
01.01.1995Drugs of the Future 1995; 20:11-15
Schwendener R., Horber Daniel, Ottiger C., Rentsch K.M., Fiebig H.H., Schott H.
Preclinical properties of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabino-furanosylcytosine in liposomal preparations
Schwendener R, Horber D, Ottiger C, Schott H. Preclinical properties of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabino-furanosylcytosine in liposomal preparations. J Liposome Res 1995; 5:27-47.
01.01.1995Preclinical properties of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabino-furanosylcytosine in liposomal preparations
01.01.1995J Liposome Res 1995; 5:27-47
Schwendener R., Horber Daniel, Ottiger C., Schott H.